News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Gonzalo Casino, Director General Cencora Pharmalex Iberia
#NewAseBioMember | "AseBio is a meeting point for the sector and a platform for the Spanish biotechnology industry"
Healthcare · Corporate
Meet our new member Cencora Pharmalex. We spoke with Gonzalo Casino Fernández, Director General…
AseBio - PHARMALEZ SPAIN S.L.U
Entrega de los Premios Nacionales de Innovación y de Diseño 2024 a BIOLAN
BIOLAN awarded the 2024 National Innovation Prize, presented by queen Letizia
Talento
The Bizkaia-based biotechnology company received the award at the Royal Palace of El Pardo (Madrid…
Partners - Biolan
20251009 TOVX October Medical Meetings-Spanish
Theriva™ Biologics anuncia varias presentaciones en congresos médicos
Access to innovation
VCN-01 expanded mPDAC data from VIRAGE Phase 2b trial to be presented at ESMO 2025 
Partners - THERIVA BIOLOGICS S.L.
PreClin VCN-12 Data@ESGCT
Theriva™ Biologics Announces Presentation Describing Next Generation Oncolytic Adenovirus VCN-12 at the 32nd Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Healthcare
Preclinical data for VCN-12, the next candidate from Theriva’s VCN-X discovery program, highlight a…
Partners - THERIVA BIOLOGICS S.L.
PCB imagen recurso
Public research at the Barcelona Science Park – UB reaches a record investment of €84 million in 2024
Healthcare
The public research institutes, together with the units and groups of the University of Barcelona (…
Partners - Parc Científic de Barcelona
Sede Natac
Natac records revenues of €31.88 million through mid-October
Healthcare
The company expects to close the year with sales exceeding €50 million and an EBITDA above €20…
Partners - Natac Group
Asabys co-lidera la Series B de Qida de €37M
Qida raises €37 million to continue improving the quality of life of the senior segment at home
Financing
The investment will enable Qida to boost growth, technological innovation, and the attraction of…
Partners - Asabys Partners
Imagen recurso de unos pulmones
BCN HEALTH publica un estudio evaluando la incidencia y el coste de la enfermedad renal crónica en España
Healthcare
BCN HEALTH has published in the Journal of Medical Economics a study analyzing the incidence,…
Partners - BCN Health
oryzon
ORYZON announces First‑Patient‑In (FPI) in RESTORE Phase Ib trial of iadademstat in sickle cell disease
Healthcare
Recently approved by the European Medicines Agency, RESTORE will evaluate iadademstat’s ability to…
Partners - Oryzon Genomics